Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share (Details) - Schedule of Outstanding Shares Potentially Dilutive Securities

v3.24.2.u1
Net Income (Loss) Per Share (Details) - Schedule of Outstanding Shares Potentially Dilutive Securities - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Schedule of Outstanding Shares Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 102,725,620 167,076,669 263,683,787 167,076,669
Options to purchase common stock [Member]        
Schedule of Outstanding Shares Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 13,088,427 1,334,309 13,088,427 1,334,309
Warrants to purchase common stock [Member]        
Schedule of Outstanding Shares Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 4,784,193 4,784,193 4,784,193 4,784,193
Restricted stock units [Member]        
Schedule of Outstanding Shares Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 10,000 10,000
Series B-1 preferred stock        
Schedule of Outstanding Shares Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 50,000,000 50,000,000
Common stock issuable upon conversion of Series A-2 Prime convertible preferred stock [Member]        
Schedule of Outstanding Shares Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 34,843,000 34,843,000
Warrants to purchase convertible preferred stock [Member]        
Schedule of Outstanding Shares Potentially Dilutive Securities [Line Items]        
Antidilutive Securities 160,958,167 160,958,167 160,958,167